Role of monocarboxylate transporters in human cancers : state of the art

Detalhes bibliográficos
Autor(a) principal: Pinheiro, Céline
Data de Publicação: 2012
Outros Autores: Longatto Filho, Adhemar, Azevedo, João Silva, Casal, Margarida, Schmitt, Fernando C., Baltazar, Fátima
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/21367
Resumo: Monocarboxylate transporters (MCTs) belong to the SLC16 gene family, presently composed by 14 members. MCT1-MCT4 are proton symporters, which mediate the transmembrane transport of pyruvate, lactate and ketone bodies. The role of MCTs in cell homeostasis has been characterized in detail in normal tissues, however, their role in cancer is still far from understood. Most solid tumors are known to rely on glycolysis for energy production and this activity leads to production of important amounts of lactate, which are exported into the extracellular milieu, contributing to the acidic microenvironment. In this context, MCTs will play a dual role in the maintenance of the hyper-glycolytic acidresistant phenotype of cancer, allowing the maintenance of the high glycolytic rates by performing lactate efflux, and pH regulation by the co-transport of protons. Thus, they constitute attractive targets for cancer therapy, which have been little explored. Here we review the literature on the role of MCTs in solid tumors in different locations, such as colon, central nervous system, breast, lung, gynecologic tract, prostate, stomach, however, there are many conflicting results and in most cases there are no functional studies showing the dependence of the tumors on MCT expression and activity. Additional studies on MCT expression in other tumor types, confirmation of the results already published as well as additional functional studies are needed to deeply understand the role of MCTs in cancer maintenance and aggressiveness.
id RCAP_c0c543135848699e3e7fe8bc652b9e50
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/21367
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Role of monocarboxylate transporters in human cancers : state of the artMonocarboxylate transportersCancerWarburg effectLactateScience & TechnologyMonocarboxylate transporters (MCTs) belong to the SLC16 gene family, presently composed by 14 members. MCT1-MCT4 are proton symporters, which mediate the transmembrane transport of pyruvate, lactate and ketone bodies. The role of MCTs in cell homeostasis has been characterized in detail in normal tissues, however, their role in cancer is still far from understood. Most solid tumors are known to rely on glycolysis for energy production and this activity leads to production of important amounts of lactate, which are exported into the extracellular milieu, contributing to the acidic microenvironment. In this context, MCTs will play a dual role in the maintenance of the hyper-glycolytic acidresistant phenotype of cancer, allowing the maintenance of the high glycolytic rates by performing lactate efflux, and pH regulation by the co-transport of protons. Thus, they constitute attractive targets for cancer therapy, which have been little explored. Here we review the literature on the role of MCTs in solid tumors in different locations, such as colon, central nervous system, breast, lung, gynecologic tract, prostate, stomach, however, there are many conflicting results and in most cases there are no functional studies showing the dependence of the tumors on MCT expression and activity. Additional studies on MCT expression in other tumor types, confirmation of the results already published as well as additional functional studies are needed to deeply understand the role of MCTs in cancer maintenance and aggressiveness.SpringerUniversidade do MinhoPinheiro, CélineLongatto Filho, AdhemarAzevedo, João SilvaCasal, MargaridaSchmitt, Fernando C.Baltazar, Fátima2012-032012-03-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/21367eng0145-479X10.1007/s10863-012-9428-122407107http://link.springer.com/article/10.1007%2Fs10863-012-9428-1info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:42:05Zoai:repositorium.sdum.uminho.pt:1822/21367Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:39:15.222989Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Role of monocarboxylate transporters in human cancers : state of the art
title Role of monocarboxylate transporters in human cancers : state of the art
spellingShingle Role of monocarboxylate transporters in human cancers : state of the art
Pinheiro, Céline
Monocarboxylate transporters
Cancer
Warburg effect
Lactate
Science & Technology
title_short Role of monocarboxylate transporters in human cancers : state of the art
title_full Role of monocarboxylate transporters in human cancers : state of the art
title_fullStr Role of monocarboxylate transporters in human cancers : state of the art
title_full_unstemmed Role of monocarboxylate transporters in human cancers : state of the art
title_sort Role of monocarboxylate transporters in human cancers : state of the art
author Pinheiro, Céline
author_facet Pinheiro, Céline
Longatto Filho, Adhemar
Azevedo, João Silva
Casal, Margarida
Schmitt, Fernando C.
Baltazar, Fátima
author_role author
author2 Longatto Filho, Adhemar
Azevedo, João Silva
Casal, Margarida
Schmitt, Fernando C.
Baltazar, Fátima
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Pinheiro, Céline
Longatto Filho, Adhemar
Azevedo, João Silva
Casal, Margarida
Schmitt, Fernando C.
Baltazar, Fátima
dc.subject.por.fl_str_mv Monocarboxylate transporters
Cancer
Warburg effect
Lactate
Science & Technology
topic Monocarboxylate transporters
Cancer
Warburg effect
Lactate
Science & Technology
description Monocarboxylate transporters (MCTs) belong to the SLC16 gene family, presently composed by 14 members. MCT1-MCT4 are proton symporters, which mediate the transmembrane transport of pyruvate, lactate and ketone bodies. The role of MCTs in cell homeostasis has been characterized in detail in normal tissues, however, their role in cancer is still far from understood. Most solid tumors are known to rely on glycolysis for energy production and this activity leads to production of important amounts of lactate, which are exported into the extracellular milieu, contributing to the acidic microenvironment. In this context, MCTs will play a dual role in the maintenance of the hyper-glycolytic acidresistant phenotype of cancer, allowing the maintenance of the high glycolytic rates by performing lactate efflux, and pH regulation by the co-transport of protons. Thus, they constitute attractive targets for cancer therapy, which have been little explored. Here we review the literature on the role of MCTs in solid tumors in different locations, such as colon, central nervous system, breast, lung, gynecologic tract, prostate, stomach, however, there are many conflicting results and in most cases there are no functional studies showing the dependence of the tumors on MCT expression and activity. Additional studies on MCT expression in other tumor types, confirmation of the results already published as well as additional functional studies are needed to deeply understand the role of MCTs in cancer maintenance and aggressiveness.
publishDate 2012
dc.date.none.fl_str_mv 2012-03
2012-03-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/21367
url http://hdl.handle.net/1822/21367
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0145-479X
10.1007/s10863-012-9428-1
22407107
http://link.springer.com/article/10.1007%2Fs10863-012-9428-1
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132932245291008